Advanced Enzyme Technologies Ltd

Advanced Enzyme Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Advanced Enzyme Technologies Ltd

₹ 275 -0.11%
30 May - close price
advancedenzymes.com BSE: 540025 NSE : ADVENZYMES
About

Advanced Enzyme Technologies Limited is engaged in the business of manufacturing and sales of enzymes.[1]

Key Points

Market Position
The Co. is the 1st Indian enzyme company with 2nd highest market share in India. It is the 2nd listed integrated enzyme player globally. [1]

Website BSE NSE
  • Market Cap ₹ 3,078 Cr.
  • Current Price ₹ 275
  • High / Low ₹ 324 / 225
  • Stock P/E 28.8
  • Book Value ₹ 110
  • Dividend Yield 1.45 %
  • ROCE 12.3 %
  • ROE 9.18 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 19.5%

Cons

  • The company has delivered a poor sales growth of 6.69% over past five years.
  • Company has a low return on equity of 12.0% over last 3 years.
  • Promoter holding has decreased over last 3 years: -8.01%
  • Working capital days have increased from 195 days to 359 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023
110 110 120 138 133 137 127 134 132 121 139 142 139
62 59 62 71 78 74 78 85 91 90 99 100 95
Operating Profit 49 52 59 66 55 63 49 49 40 31 40 42 44
OPM % 44% 47% 49% 48% 41% 46% 39% 37% 31% 26% 29% 29% 32%
2 5 1 1 2 1 1 1 3 2 4 9 7
Interest 1 0 0 0 0 0 0 0 1 1 1 1 1
Depreciation 7 7 7 6 9 8 9 9 9 9 9 9 8
Profit before tax 43 50 52 61 48 55 41 41 34 24 34 40 42
Tax % 24% 30% 26% 27% 29% 27% 27% 31% 26% 26% 23% 31% 24%
Net Profit 33 35 39 44 34 40 30 29 25 18 26 28 32
EPS in Rs 2.81 3.07 3.33 3.86 2.81 3.40 2.66 2.46 2.19 1.60 2.34 2.63 2.87
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
171 219 239 222 293 329 391 420 444 502 529 541
109 130 189 131 155 177 226 236 241 269 327 384
Operating Profit 62 90 50 91 138 152 165 184 203 233 203 156
OPM % 36% 41% 21% 41% 47% 46% 42% 44% 46% 46% 38% 29%
3 4 1 1 -3 3 1 5 6 9 6 21
Interest 12 10 13 9 8 4 9 5 4 3 3 2
Depreciation 6 8 10 9 9 13 18 21 26 29 35 35
Profit before tax 48 76 28 74 118 137 139 162 179 210 171 140
Tax % 29% 34% 23% 31% 35% 32% 33% 28% 26% 28% 28% 26%
Net Profit 34 50 21 51 77 93 94 116 133 151 124 104
EPS in Rs 3.22 4.52 1.85 4.60 6.97 8.20 8.07 9.95 11.58 13.06 10.70 9.45
Dividend Payout % 1% 7% 6% 4% 3% 5% 6% 6% 5% 7% 9% 42%
Compounded Sales Growth
10 Years: 9%
5 Years: 7%
3 Years: 7%
TTM: 2%
Compounded Profit Growth
10 Years: 8%
5 Years: 3%
3 Years: -6%
TTM: -10%
Stock Price CAGR
10 Years: %
5 Years: 5%
3 Years: 22%
1 Year: -4%
Return on Equity
10 Years: 16%
5 Years: 14%
3 Years: 12%
Last Year: 9%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
21 22 22 22 22 22 22 22 22 22 22 22
Reserves 75 140 145 188 256 442 537 657 817 949 1,066 1,213
207 186 167 115 101 54 67 35 28 28 35 34
46 48 73 92 71 65 102 91 104 150 137 153
Total Liabilities 349 396 406 417 450 583 727 805 971 1,149 1,260 1,422
204 287 287 287 285 421 491 495 563 604 619 655
CWIP 60 2 2 5 7 8 11 10 10 10 15 16
Investments 0 0 0 0 0 0 0 111 124 121 102 360
84 107 117 125 158 153 226 188 275 414 524 392
Total Assets 349 396 406 417 450 583 727 805 971 1,149 1,260 1,422

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
49 41 43 54 93 107 116 129 141 163 122 140
-187 -40 -25 -15 -10 -60 -60 -124 -43 -27 -19 -298
128 -3 -20 -36 -63 -65 -2 -43 -39 -26 -27 -26
Net Cash Flow -10 -2 -1 2 21 -18 54 -38 60 109 75 -184

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 70 65 49 61 52 55 55 51 61 63 61 68
Inventory Days 222 318 387 403 358 352 339 363 361 346 402 343
Days Payable 139 121 81 89 68 57 78 46 43 56 60 67
Cash Conversion Cycle 152 262 356 374 342 351 315 369 379 353 404 344
Working Capital Days 60 95 5 -4 40 106 82 90 100 104 122 359
ROCE % 28% 26% 12% 25% 37% 32% 26% 25% 23% 23% 16% 12%

Shareholding Pattern

Numbers in percentages

Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023
58.13 55.45 55.39 55.38 52.30 52.55 52.71 52.70 52.70 49.88 49.88 49.88
11.02 16.01 17.11 16.79 16.40 16.27 16.39 18.01 18.72 21.68 21.74 21.86
8.69 6.32 6.28 7.32 8.46 8.66 8.99 6.90 6.26 5.60 5.64 5.73
22.16 22.23 21.22 20.51 22.84 22.52 21.91 22.38 22.32 22.86 22.76 22.54

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls